SCHEMBL11013255

SCHEMBL11013255

CNc1cc(Cl)cc(Cl)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.56
ALDH1A1 P00352 4/20 0.56
TSHR P16473 3/20 0.56
CYP3A4 P08684 3/20 0.56
RECQL P46063 2/20 0.56
HSPA5 P11021 1/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HPGD P15428 2/20 0.45
TTR P02766 2/20 0.45
KDM4E B2RXH2 2/20 0.45
SLC22A2 O15244 1/20 0.45
SLC22A1 O15245 1/20 0.45
NR1I2 O75469 1/20 0.45
SLC22A3 O75751 1/20 0.45
EGFR P00533 1/20 0.45
LMNA P02545 1/20 0.45
ESR1 P03372 1/20 0.45
ERBB2 P04626 1/20 0.45
LCK P06239 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18329034 0.78 WDR5 (0.40) HSD17B10ALDH1A1TSHRCYP3A4RECQL
SCHEMBL12767916 0.77 HSD17B10 (0.50) HSD17B10ALDH1A1TSHRCYP3A4RECQL
SCHEMBL7201523 0.76 HSD17B10 (0.54) HSD17B10ALDH1A1TSHRCYP3A4RECQL
SCHEMBL9400489 0.75 HSPA5 (0.58) HSD17B10ALDH1A1TSHRCYP3A4RECQL
Methyl Alcohol SCHEMBL28184301 0.75 HSD17B10 (0.88) HSD17B10ALDH1A1TSHRCYP3A4RECQL
SCHEMBL13253953 0.74 ALDH1A1 (0.38) HSD17B10ALDH1A1TSHRCYP3A4RECQL
SCHEMBL8872103 0.74 HSD17B10 (1.00) HSD17B10ALDH1A1TSHRCYP3A4RECQL
SCHEMBL184648 0.74 HSD17B10 (1.00) HSD17B10ALDH1A1TSHRCYP3A4RECQL
SCHEMBL6410292 0.74 HSPA5 (0.62) HSD17B10ALDH1A1TSHRCYP3A4RECQL
SCHEMBL25065902 0.73 ALDH1A1 (0.36) HSD17B10ALDH1A1TSHRCYP3A4RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962244-B2 Compounds for modulating RNA binding proteins and uses therefor UNIVERSITY OF MASSACHUSETTS (US) 2015-02-24 US disclosed
US-20130217685-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR UNIVERSITY OF MASSACHUSETTS (US) 2013-08-22 US disclosed
US-8377639-B2 Compounds for modulating RNA binding proteins and uses therefor UNIVERSITY OF MASSACHUSETTS (US) 2013-02-19 US disclosed
US-20110065704-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-03-17 US disclosed
EP-1742105-A2 Photothermographic material Fuji Photo Film Co., Ltd. (JP) 2007-01-10 EP disclosed
EP-0135017-A1 Process for the stabilisation of poly(phenylene ether) solutions BASF Aktiengesellschaft (DE) 1985-03-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217685-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR TIA1, ZFP3, RBM3 HSD17B10 4439/4885ALDH1A1 3135/4885TSHR 4273/4885
US-20110065704-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR TIA1, ZFP3, RBM3 HSD17B10 4439/4885ALDH1A1 3135/4885TSHR 4273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.